Theoretical and experimental determination of dosimetric characteristics for brachyseed™ Pd-103, model Pd-1, source

Applied Radiation and Isotopes

Volumn 58, Issue 5, 2003, Pages 533-541

  Meigooni, Ali S ^a   Zhang, Hualin ^a   Perry, Candace ^a   Dini, Sharifeh A ^a   Koona, Rafiq A ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

103Pd; Brachytherapy; Dosimetry; TG 43; Thermoluminescent dosimeter

Indexed keywords

ANISOTROPY; COMPUTER SIMULATION; MONTE CARLO METHODS; RATE CONSTANTS; SOLID WASTES;

PHANTOM MATERIALS; RADIAL DOSE FUNCTIONS;

DOSIMETRY;

PALLADIUM 103; PALLADIUM; RADIOISOTOPE;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; CALIBRATION; DEVICE; DOSIMETRY; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE; SIMULATION; THEORY; BIOLOGICAL MODEL; CHEMISTRY; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; HUMAN; INSTRUMENTATION; METHODOLOGY; RADIOMETRY; STANDARD; UNCERTAINTY;

ANISOTROPY; BRACHYTHERAPY; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; PALLADIUM; RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; UNCERTAINTY;

EID: 0038486834     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(02)00349-4     Document Type: Article

References (20)

1. 125I implantation for Stage T1/T2 Prostate carcinoma. J. Urol. 154:1995;1096-1099.
2. Briesmeister, J.F., 2000. MCNP - a general Monte Carlo N-particle transport code. Version 4C, Los Alamos National Laboratory Report LA-12625.
3. 103Pd seeds (model 200) in solid water phantom. Med. Phys. 18:1991;449-452.
4. 125I prostate implant followed by external beam radiation Cancer J. Sci. Am. 4:1998;359-363.
5. 125I brachytherapy source. Med. Phys. 27:2000;2278-2285.
6. Hubbell, J.H., Seltzer, S.M., 1995. Table of X-ray mass atomic attenuation coefficient and mass energy absorption coefficient 1 keV to 20 MeV for Elements Z=1 to 98 and 48 additional substances of dosimetric Interest. NISTIR 5632, National Institute of Standard and Technology.
7. Meigooni A.S., Mishra V., Panth H., Williamson J.F. Instrumentation and dosimeter-size artifacts in quantitative thermoluminescent dosimetry of low-dose fields. Med. Phys. 22(5):1995;555-561.
8. 103palladium brachytherapy source. Med. Phys. 27:2000;1093-1100.
9. 103Pd brachytherapy source. Med. Phys. 28:2001;2568-2575.
10. Nag S., Beyer D., Friedland J., Grimm P., Nath R. American Brachytherapy Society (ABS) recommendation for transperineal permanent brachytherapy of prostate cancer. Int. J. Radit. Oncol. Biol. Phys. 44:1999;789-799.
11. Nath R., Anderson L.L., Luxton G., Weaver K.A., Williamson J.F., Meigooni A.S. Dosimetry of interstitial brachytherapy sources. recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 Med. Phys. 22(2):1995;109-234.
12. Nori D. Conformal brachytherapy of prostate cancer. an effective outpatient treatment Cancer Watch. 1:1992;124-126.
13. Porrazzo M.S., Hilaris B.S., Moorthy C.R., Tchelebi A.E., Mastoras C.A., Shih L.L., Stabile L., Salvaras N. Permanent interstitial implantation using palladium-103. the New York Medical College preliminary experience Int. J. Rad. Onc. Biol. Phys. 23:1992;1033-1036.
14. Russell K.J., Blasko J.C. Recent advances in interstitial brachytherapy for localized prostate cancer. Problems Urol. 7(2):1993;260-278.
15. Stone N.N., Stock R.G. Prostate brachytherapy. treatment strategies J. Urol. 162:1999;421-426.
16. 103Pd brachytherapy source. Med. Phys. 26:1999;2465-2470.
17. 103Pd sources. Med. Phys. 25(12):1998;2271-2278.
18. 103Pd interstitial brachytherapy source. Med. Phys. 27(4):2000;643-654.
19. Williamson J.F., Coursey B.M., DeWerd L.A., Hanson W.F., Nath R., Ibbott G.S. Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources. Med. Phys. 25(12):1998;2269-2278.
20. 125I interstitial sources; dosimetry and calibration changes. Med. Phys. 26(4):1999;570-573.